Skip to content
‹ Back to IndustriesHealthcare

Encouraging the Adoption of Value-Based Care

How are Precision Health Insight Networks (PHINs) laying the groundwork for mainstream adoption of precision health? While recognized for its promise to save millions of lives and billions of dollars, the advancement of precision medicine has been limited to only a handful of conditions due to data silos and disconnected databases. The power of PHINs…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

How are Precision Health Insight Networks (PHINs) laying the groundwork for mainstream adoption of precision health? While recognized for its promise to save millions of lives and billions of dollars, the advancement of precision medicine has been limited to only a handful of conditions due to data silos and disconnected databases.

The power of PHINs was on full display during COVID-19. Now, these award-winning solutions are poised to drive innovations across many disease states.

Brad Bostic, CEO of HC1, had this to say about the topic.

“So, I’ve been often asked the question about personalized medicine and the practical nature of that, and, ultimately, will it ever be mainstream?

My point of view on that is absolutely it will be. What I see happening right now within health care is this Renaissance that gives us a chance at getting there sooner rather than later.

The first part of that being the incentive models in healthcare, where, historically, we’ve been focused on a fee-for-service model. That incentivizes volume, and it doesn’t really allow for the idea of anything being personalized.

In fact, I’d say it’s quite the opposite. If you’re volume-motivated, you’re looking at it more like widgets. How do I do as much as I can, as fast as I can? And it’s not intended to deliver a bad outcome to patients, but there’s just not the right incentive there.

What we have emerging now is more of a value-based model.

We now know enough about how much it should cost to take care of different conditions. And, if you implement best practices to take care of those conditions and you effectively manage those patients, you can have a budget like a bucket of money per person in a given disease state or a given demographic within a population to care for them.

If you can do it in a way that costs less than what you were allocated, you can make more profit, so that’s creating an incentive. That’s clearing the way for programs that healthcare leaders are interested in investing in — precision healthcare types of models. A specific example of that would be the ability to truly identify those people in your population that are taking medications that aren’t working for them and doing that by looking at a combination of that person’s diagnosis, that person’s medication list, and that person’s specific genomic profile.

It’s something that I believe will become extremely widespread in the coming months and years. In fact, I once had the head of the health plan for one of the largest technology companies on earth say to me, in the next five years, it will be considered criminal negligence to not perform these precision prescribing kinds of tests like pharmacogenetics, and that was a very extreme statement.

But his point was, if we know we have a test that’s relatively low cost, that can determine what medication is going to work for you and prevent you from having a heart stent or potentially some kind of catastrophic cardiac arrest event. why would we allow that not to happen? Why would we not run that test to make sure that we’re getting you on the optimal medication? And that’s just one small example.

I think ultimately, though, what we’ll find is the kind of experience that we’ve grown to appreciate and expect from consumer services.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why hospitals stagger security upgrades instead of shutting down

Why hospitals stagger security upgrades instead of shutting down

Parabit Systems' Robert Iraggi told A Weekly Bit that hospital security upgrades must be planned and staggered because the building never closes. OSHA counted 7.8 serious violent injuries per 10,000 healthcare workers in 2013 against under two in construction, and Joint Commission EP 17 requires an annual worksite analysis. Illinois biometric law adds a consent step for facial recognition.

  • 01OSHA counted 7.8 serious violent injuries per 10,000 healthcare workers in 2013; construction, manufacturing and retail each stayed under two.
  • 02Joint Commission EP 17 has required an annual workplace violence worksite analysis since January 2022, and hospitals are expected to act on what it finds—making phased security upgrades easier to document year to year.
  • 03Squire Patton Boggs counted at least 100 Illinois biometric privacy class actions filed in 2025, and Illinois’ BIPA requires notice and consent for collecting biometrics—so a facial-recognition rollout plan should include the notice, consent record, and retention controls before the first camera goes live.

Nov 17, 2026

Sterile processing deviations become the norm without stop-and-document rules

Sterile processing deviations become the norm without stop-and-document rules

Advanced Sterilization Products' Tamara Beeler told Censis Technologies' CtUC 2026 audience that sterile processing deviations harden into norms when departments don’t stop, escalate and document them. She connects ANSI/AAMI ST108:2023 water categories, daily cleaning verification, loaner-tray refusal when sets arrive late or lack IFUs, and root cause analysis when rework repeats on the same device.

  • 01ANSI/AAMI ST108:2023 turned water quality for instrument reprocessing into an enforceable standard; AAMI's earlier TIR34 was guidance with no enforcement behind it.
  • 02Some facilities require loaner trays 48 hours before a case, and ASP's Tamara Beeler says a technician at any level can refuse one that arrives late, undocumented or dirty.
  • 03Rework that returns on the same device is the point at which Beeler wants a root cause analysis opened, with the record kept in the instrument tracking system.

Nov 17, 2026

TheraPanacea aims to spread best-center radiotherapy quality

TheraPanacea aims to spread best-center radiotherapy quality

TheraPanacea CEO Nikos Paragios says the company's two objectives are to carry best-center radiotherapy quality to every patient and to pick each patient's treatment at the start from multimodal data. A 2026 Nature Communications trial of 500 patients found AI-assisted contouring lifted mean Dice overlap from 0.857 to 0.902, and Siemens Healthineers CE-marked its own AI contouring in May 2026.

  • 01TheraPanacea's two stated objectives: carry best-center radiotherapy quality to every patient on the globe, and identify each patient's best treatment at the start from imaging and clinical history.
  • 02A 2026 Nature Communications trial of 500 patients across five centers found AI-assisted contouring lifted mean Dice overlap from 0.857 to 0.902 and cut median contouring time from 55 to 10 minutes, with less variation between centers.
  • 03Siemens Healthineers' Varian business CE-marked AI contouring for Eclipse in May 2026, so Paragios locates TheraPanacea's edge in its team, hospital partnerships and impact focus rather than in the algorithm alone.

Nov 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512